Cervical Cancer Control, Priorities and New Directions (2004)
Monsonego, J, Bosch, FX, Coursaget, P, Cox, JT, Franco, E, Frazer, I, ...
Cervical cancer is caused by infection with a range of high risk oncogenic human papillomavirus (HPV) types, and it is now accepted that >99% of cervical cancer is initiated by HPV infection. The...
Cervical Cancer Control, Priorities and New Directions (2004)
Monsonego, J, Bosch, FX, Coursaget, P, Cox, JT, Franco, E, Frazer, I, ...
Cervical cancer is caused by infection with a range of high risk oncogenic human papillomavirus (HPV) types, and it is now accepted that >99% of cervical cancer is initiated by HPV infection. The...
Evidence for activation of cellular immune responses in patients with acute hepatitis E. (2002)
Naik, S, Aggarwal, R, Naik, SR, Dwivedi, S, Talwar, S, Tyagi, SK, ...
Intégration du vaccin contre l'hépatite B dans les programmes élargis de vaccination (1991)
Coursaget, P., Relyveld, E., Yvonnet, B., Sarr, G., Bringer, L., Bourdil, C., ...
Thèse univ. : Tours : Pharm. : 1974 ; no 3.
In vitro gene transfer using human papillomavirus-like particles.
Recombinant papillomavirus-like particles have recently been shown to be highly effective for the prevention of papillomavirus infections and associated tumors, and a virus-like particle-based...
Le Cann, P, Touze, A, Enogat, N, Leboulleux, D, Mougin, C, Legrand, M C, ...
The L1 major capsid protein of human papillomavirus type 16 (HPV-16) was expressed in Sf-21 insect cells with a recombinant baculovirus. Virus-like particles obtained were purified and used to...
Coursaget, P, Yvonnet, B, Relyveld, E H, Barres, J L, Diop-Mar, I, Chiron, J P
We studied the interactions of hepatitis B vaccine with other vaccines used in the World Health Organization expanded programs of immunization. Three groups of Senegalese children were vaccinated...
Barin, F, Yvonnet, B, Goudeau, A, Coursaget, P, Chiron, J P, Denis, F, ...
Three doses of inactivated hepatitis B vaccine were given at 1-month intervals to 31 hepatitis B surface antigen (HBsAg)-positive Senegalese children aged between 3 and 24 months. A control group of...
Coursaget, P, Maupas, P, Goudeau, A, Drucker, J
A study of the serological markers of Hepatitis B virus (HBV) including e antigen (HBe Ag) and antibody against HBe Ag (anti-HBe) was performed in Senegalese patients suffering from cirrhosis and...
Antibody to hepatitis B core antigen in chronic active hepatitis.
Bories, P, Coursaget, P, Goudeau, A, Degott, C, Maupas, P, Benhamou, J P
Antibody to hepatitis B core antigen (anti-HBc), which has been assumed to be a more sensitive indicator of hepatitis B virus replication than hepatitis B surface antigen (HBsAg), was detected in the...
In vitro gene transfer using human papillomavirus-like particles.
Recombinant papillomavirus-like particles have recently been shown to be highly effective for the prevention of papillomavirus infections and associated tumors, and a virus-like particle-based...
Le Cann, P, Touze, A, Enogat, N, Leboulleux, D, Mougin, C, Legrand, M C, ...
The L1 major capsid protein of human papillomavirus type 16 (HPV-16) was expressed in Sf-21 insect cells with a recombinant baculovirus. Virus-like particles obtained were purified and used to...
Coursaget, P, Yvonnet, B, Relyveld, E H, Barres, J L, Diop-Mar, I, Chiron, J P
We studied the interactions of hepatitis B vaccine with other vaccines used in the World Health Organization expanded programs of immunization. Three groups of Senegalese children were vaccinated...
Barin, F, Yvonnet, B, Goudeau, A, Coursaget, P, Chiron, J P, Denis, F, ...
Three doses of inactivated hepatitis B vaccine were given at 1-month intervals to 31 hepatitis B surface antigen (HBsAg)-positive Senegalese children aged between 3 and 24 months. A control group of...
Coursaget, P, Maupas, P, Goudeau, A, Drucker, J
A study of the serological markers of Hepatitis B virus (HBV) including e antigen (HBe Ag) and antibody against HBe Ag (anti-HBe) was performed in Senegalese patients suffering from cirrhosis and...
Antibody to hepatitis B core antigen in chronic active hepatitis.
Bories, P, Coursaget, P, Goudeau, A, Degott, C, Maupas, P, Benhamou, J P
Antibody to hepatitis B core antigen (anti-HBc), which has been assumed to be a more sensitive indicator of hepatitis B virus replication than hepatitis B surface antigen (HBsAg), was detected in the...
Cervical cancer control, priorities and new directions
Monsonego, J, Bosch, FX, Coursaget, P, Cox, JT, Franco, E, Frazer, I, ...
Cervical cancer is caused by infection with a range of high risk oncogenic human papillomavirus (HPV) types, and it is now accepted that >99% of cervical cancer is initiated by HPV infection. The...
Clinical trial of hepatitis B vaccine in a simplified immunization programme.
Coursaget, P., Yvonnet, B., Sarr, M., Vincelot, P., Tortey, E., Mboup, S., ...
High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal.
Coursaget, P., Depril, N., Chabaud, M., Nandi, R., Mayelo, V., LeCann, P., ...
In hepatocellular carcinoma, mutation within the p53 gene occurs mainly at codon 249 and its frequency has been associated with exposure to aflatoxin. As Senegal is a country where liver cancer...
Antibody levels against BK virus and prostate, kidney and bladder cancers in the EPIC-Oxford cohort
Newton, R, Ribeiro, T, Casabonne, D, Alvarez, E, Touzé, A, Key, T, ...
In a case–control study nested within the EPIC-Oxford cohort, there were no statistically significant differences in the prevalence or titre of antibodies against BK virus measured in plasma taken...
The epidemiology of conjunctival squamous cell carcinoma in Uganda
Newton, R, Ziegler, J, Ateenyi-Agaba, C, Bousarghin, L, Casabonne, D, Beral, V, ...
As part of a larger investigation of cancer in Uganda, we conducted a case–control study of conjunctival squamous cell carcinoma in adults presenting at hospitals in Kampala. Participants were...